Related Experiment Video
Updated: Jun 22, 2026

Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
Published on: April 24, 2020
Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations
Sarah Ringold1, Kristy D Seidel, Thomas D Koepsell
1Division of Rheumatology, University of Washington and Seattle Children's Hospital, Seattle, WA 98105, USA. sarah.ringold@seattlechildrens.org
Insights
Children with polyarticular juvenile idiopathic arthritis (JIA) often experience active disease. Early joint damage and RF(+) status are linked to more active disease, suggesting these subgroups need targeted interventions for better outcomes.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Clinical Medicine
Background:
- Polyarticular juvenile idiopathic arthritis (JIA) is a chronic autoimmune condition affecting multiple joints in children.
- Achieving inactive disease (ID) and remission are key treatment goals in pediatric rheumatology.
- Understanding factors associated with disease activity is crucial for optimizing JIA management.
Purpose of the Study:
- To determine the rates of inactive disease and remission in children with polyarticular JIA.
- To investigate associations between patient characteristics, imaging findings, and disease activity outcomes.
- To identify subgroups of JIA patients with higher disease burden.
Main Methods:
- Retrospective cohort study of 104 children with polyarticular JIA.
- Disease status (active disease vs. ID) assessed at each clinic visit over an average 30-month follow-up.
- Mantel-Haenszel methods used to calculate adjusted relative risk estimates.
Main Results:
- Patients spent a mean of 66.3% of follow-up with active disease.
- Children with early joint damage on imaging had significantly more active disease (79% vs. 58.5%, P < 0.001).
- Rheumatoid factor positive (RF(+)) status and early joint damage were associated with higher active disease prevalence.
Conclusions:
- The majority of the follow-up period for children with polyarticular JIA is characterized by active disease.
- Early radiographic evidence of joint damage and RF(+) status identify high-risk subgroups requiring focused therapeutic strategies.
- Improving outcomes for these specific JIA patient subgroups should be a priority for future research and clinical practice.
Objectives:
To describe the achievement of inactive disease (ID) and remission in polyarticular juvenile idiopathic arthritis (JIA) and to measure the associations among patient characteristics, imaging results and these outcomes.
Methods:
We performed a retrospective cohort study of children with polyarticular JIA diagnosed and treated at Seattle Children's Hospital between 1 January 2000 and 31 December 2006. Each patient's disease status (active disease vs ID) was determined for every clinic visit. Adjusted relative risk estimates were obtained using Mantel-Haenszel methods.
Results:
One hundred and four children were included. Patients were followed up for an average of 30 months. Patients achieved 138 episodes of ID. Fifty-one patients achieved 69 episodes of clinical remission on medication. When duration of active disease was summed over each patient's follow-up, patients spent a mean of 66.3% of their follow-up with active disease. Patients with evidence of joint damage on imaging studies obtained within 6 months of their first clinic visit spent a mean of 79% of their follow-up with active disease. Patients without these findings spent a mean of 58.5% of their follow-up with active disease (P < 0.001). Children who were RF(+) and children with early evidence of joint damage tended to have a higher prevalence of active disease during the follow-up period.
Conclusions:
In this cohort, children with polyarticular JIA spent the majority of their follow-up with active disease. Because children with early radiographic evidence of joint damage and children who were RF(+) tended to have the most active disease, improving outcomes for these subgroups may be an important goal for prospective study.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Inflammatory Bowel Disease IV: Clinical Manifestations
Rheumatic Heart Disease I: Introduction
The JAK-STAT Signaling Pathway
Inflammatory Bowel Disease III: Crohn's Disease
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...